LON:RUA RUA Life Sciences (RUA) Share Price, News & Analysis → Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad) Free RUA Stock Alerts GBX 12.25 -1.12 (-8.38%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range 12▼ 13.1150-Day Range 8.75▼ 13.3852-Week Range 8.50▼ 58.75Volume513,998 shsAverage Volume750,399 shsMarket Capitalization£7.60 millionP/E RatioN/ADividend Yield1.44%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get RUA Life Sciences alerts: Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About RUA Life Sciences Stock (LON:RUA)RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturing, assembly, packing and services to the medical device. The Vascular segment develops bore polymer sealed grafts and soft tissue patches. The Structural Heart segment manufactures synthetic heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Ayrshire, the United Kingdom.Read More RUA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RUA Stock News HeadlinesMay 21, 2024 | americanbankingnews.comRUA Life Sciences (LON:RUA) Stock Price Up 9.5%See More Headlines Receive RUA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RUA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:RUA CUSIPN/A CIKN/A Webwww.rualifesciences.com Phone44 1294 317073FaxN/AEmployees48Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-1,870,000.00 Net Margins-100.05% Pretax MarginN/A Return on Equity-40.56% Return on Assets-27.86% Debt Debt-to-Equity Ratio11.92 Current Ratio2.67 Quick Ratio7.32 Sales & Book Value Annual Sales£1.87 million Price / Sales4.07 Cash FlowGBX 5.11 per share Price / Cash Flow2.40 Book ValueGBX 17 per share Price / Book0.72Miscellaneous Outstanding Shares62,060,000Free FloatN/AMarket Cap£7.60 million OptionableNot Optionable Beta1.21 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. William Donald Brown (Age 61)Executive Chairman Comp: $266.98kMr. Lachlan Arthur Smith (Age 44)CFO & Director Comp: $139kMr. John McKenna (Age 71)Director of Clinical Marketing & Executive Director Comp: $73.78kKathryn Mary Full FCCACompany SecretaryKey CompetitorsPolarean ImagingLON:POLXAdvanced OncotherapyLON:AVOMyHealthCheckedLON:MHCSurgical Innovations GroupLON:SUNInspiration Healthcare GroupLON:IHCView All Competitors RUA Stock Analysis - Frequently Asked Questions How have RUA shares performed in 2024? RUA Life Sciences' stock was trading at GBX 9.85 at the start of the year. Since then, RUA stock has increased by 24.4% and is now trading at GBX 12.25. View the best growth stocks for 2024 here. How do I buy shares of RUA Life Sciences? Shares of RUA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:RUA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RUA Life Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.